NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Prospect Capital Management L.P. (“Prospect”), investment adviser to Prospect Capital Corporation (NASDAQ: PSEC) and other funds, announced today that Prospect has received an Honorable Mention in Mergers & Acquisitions' 2025 Middle-Market Deals of the Year Awards for Prospect's role in providing value-added capital to Druid City Infusion ("Druid City").

LONDON--(BUSINESS WIRE)--Paysafe (NYSE: PSFE), a leading payments platform, and Fiserv, Inc. (NYSE: FI), a global provider of payments and financial services technology solutions, are expanding their long-term partnership to deliver even greater value to their customers. This collaboration includes several key initiatives focused on empowering small and medium-sized businesses (SMBs). One key initiative is the integration of Fiserv's Clover Capital solution, which provides SMBs with improved ac.

The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like PCB, GIII, ROCK, PFE and PAM hold promise.

Construction Partners (ROAD) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of a loss of $0.04 per share. This compares to loss of $0.02 per share a year ago.

Ubiquiti Inc. (UI) came out with quarterly earnings of $3 per share, beating the Zacks Consensus Estimate of $1.86 per share. This compares to earnings of $1.28 per share a year ago.

InspireMD, Inc. (NSPR) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to loss of $0.21 per share a year ago.

Net revenues for the year ending December 31, 2024, totaled $54.2 million, an increase of $31.4 million, or 138.1%, compared to the previous year. Net revenues for the year ending December 31, 2024, totaled $54.2 million, an increase of $31.4 million, or 138.1%, compared to the previous year.

CENTENNIAL, CO / ACCESS Newswire / May 9, 2025 / NioCorp Developments Ltd. ("NioCorp" or the "Company") (NASDAQ:NB) is pleased to announce that it will participate in Aviation Week Network's 2025 Defense Conference at the National Press Club in Washington, D.C.

British Airways' parent, IAG, announced its first- quarter results on Friday. It said it would buy 53 more planes from Boeing and Airbus.

SAN DIEGO, May 09, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Compass Diversified Holdings (NYSE: CODI) focused on whether Compass Diversified and certain of its top executives made false and/or misleading statements and/or failed to disclose material information to investors.

NEW YORK, NY / ACCESS Newswire / May 9, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Humana Inc. ("Humana Inc.") (NYSE:HUM) concerning possible violations of federal securities laws. On May 1, 2025, the U.S. Department of Justice announced it had filed a False Claims Act complaint against several health insurance companies and insurance broker organizations, including Humana.

U.S. federal regulators, in a final environmental report, recommend Venture Global LNG's CP 2 export project in Louisiana get the go-ahead, according to a document.

Travel-services site's stock tanks after a revenue miss and downbeat bookings outlook, amid weaker-than-expected U.S. travel demand.

Monster Beverage is overvalued despite a strong market position; the S&P 500 outperformed Monster by 31% over the past two years. Q1 2025 results showed a revenue miss and a slight EPS beat; improved margins indicate operational efficiency and pricing power. The balance sheet improved with increased cash and reduced long-term debt, but the current valuation is still unattractive for long-term investment.

IOVA reports dismal first-quarter results. The share price plunges after the company significantly lowers its 2025 sales guidance.

ANI Pharmaceuticals (ANIP) came out with quarterly earnings of $1.70 per share, beating the Zacks Consensus Estimate of $1.37 per share. This compares to earnings of $1.21 per share a year ago.

Kymera Therapeutics, Inc. (KYMR) came out with a quarterly loss of $0.82 per share versus the Zacks Consensus Estimate of a loss of $0.92. This compares to loss of $0.69 per share a year ago.

The current state of marijuana stocks could keep some people discouraged. With no federal reform or bills to ease tax burdens and improve banking access, this has led to a downtrend. A volatile wave of downward trading has plagued the sector for some time. People see that money is being made for legal operators, but still, no one feels as safe and protected as they should be.

Puma Biotechnology, Inc. (NASDAQ:PBYI ) Q1 2025 Results Conference Call May 8, 2025 4:30 PM ET Company Participants Mariann Ohanesian - Senior Director Investor Relations Alan Auerbach - President & Chief Executive Officer Jeff Ludwig - Chief Commercial Officer Heather Blaber - VP of Marketing Roger Storms - VP of Sales Maximo Nougues - Chief Financial Officer Conference Call Participants Divya Rao - Cowen Operator Good afternoon. My name is Sherry, and I will be your conference call operator today.

The three stocks in this analysis all seem a bit sleepy in premarket trading, as we are looking forward to the US-China meeting over the weekend. At this point, traders have spent a lot of bullish energy in the markets, based on hope.